Dr. Eddie Patton, M.D
NPI: 1720213770
Total Payments
$235,342
2024 Payments
$71,151
Companies
51
Transactions
588
Medicare Patients
1,099
Medicare Billing
$179,697
Payment Breakdown by Category
Other$160,195 (68.1%)
Travel$28,656 (12.2%)
Consulting$26,323 (11.2%)
Food & Beverage$16,491 (7.0%)
Research$3,226 (1.4%)
Education$451.25 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $157,345 | 60 | 66.9% |
| Travel and Lodging | $28,656 | 112 | 12.2% |
| Consulting Fee | $26,323 | 11 | 11.2% |
| Food and Beverage | $16,491 | 390 | 7.0% |
| Unspecified | $3,226 | 1 | 1.4% |
| Honoraria | $2,850 | 2 | 1.2% |
| Education | $451.25 | 12 | 0.2% |
Payments by Type
General
$232,116
587 transactions
Research
$3,226
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $80,064 | 137 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $76,471 | 117 | $0 (2024) |
| ARGENX US, INC. | $35,780 | 49 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $23,565 | 38 | $0 (2024) |
| Lilly USA, LLC | $4,984 | 10 | $0 (2024) |
| Horizon Therapeutics plc | $3,235 | 8 | $0 (2023) |
| Eli Lilly and Company | $3,226 | 1 | $0 (2024) |
| ABBVIE INC. | $614.21 | 28 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $547.62 | 12 | $0 (2024) |
| Medtronic USA, Inc. | $482.09 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71,151 | 256 | Alexion Pharmaceuticals, Inc. ($31,900) |
| 2023 | $72,535 | 116 | ARGENX US, INC. ($28,882) |
| 2022 | $8,377 | 28 | Alexion Pharmaceuticals, Inc. ($5,988) |
| 2021 | $14,037 | 21 | Biogen, Inc. ($13,706) |
| 2020 | $18,412 | 24 | Biogen, Inc. ($14,104) |
| 2019 | $48,898 | 95 | Biogen, Inc. ($41,457) |
| 2018 | $790.99 | 11 | Medtronic USA, Inc. ($356.01) |
| 2017 | $1,143 | 37 | Mallinckrodt LLC ($318.63) |
All Payment Transactions
588 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Biogen, Inc. | TYSABRI (Biological) | Education | In-kind items and services | $63.00 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Rare Disease | ||||||
| 12/13/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $68.56 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,695.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Travel and Lodging | Cash or cash equivalent | $61.64 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Immunology | ||||||
| 11/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $122.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Neurology | ||||||
| 11/18/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Neuromodulation | ||||||
| 11/14/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Neuromodulation | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AN ADAPTIVE PHASE 2A/2B, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF LY3541860 COMPARED TO PLACEBO IN SLOWING THE OCCURRENCE OF NEW T1 GADOLINIUM-ENHANCING LESIONS IN ADULT PARTICIPANTS WITH RELAPSING MULTIPLE SCLEROSIS | Eli Lilly and Company | $3,226 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 256 | 342 | $138,913 | $37,688 |
| 2022 | 6 | 130 | 158 | $58,283 | $17,834 |
| 2021 | 6 | 164 | 186 | $51,876 | $15,025 |
| 2020 | 13 | 549 | 10,162 | $333,568 | $109,150 |
Total Patients
1,099
Total Services
10,848
Medicare Billing
$179,697
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 75 | $34,200 | $9,630 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 72 | $22,824 | $6,878 | 30.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 30 | 61 | $22,387 | $4,810 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $11,749 | $4,175 | 35.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $11,975 | $3,791 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 54 | $12,042 | $3,764 | 31.3% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 12 | 12 | $12,744 | $2,417 | 19.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 12 | 12 | $10,992 | $2,223 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 35 | $15,960 | $5,050 | 31.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 21 | 38 | $13,946 | $3,159 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $9,096 | $3,118 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 25 | $7,925 | $2,588 | 32.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $6,227 | $2,333 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 23 | $5,129 | $1,586 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 65 | $14,950 | $4,798 | 32.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 27 | 29 | $6,528 | $2,859 | 43.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 16 | 30 | $11,010 | $2,532 | 23.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 20 | $9,120 | $1,986 | 21.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 25 | $3,825 | $1,439 | 37.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $6,443 | $1,411 | 21.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 14 | 9,502 | $114,024 | $46,037 | 40.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 143 | 197 | $45,310 | $15,335 | 33.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 95 | 95 | $36,101 | $11,411 | 31.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 61 | 84 | $37,174 | $9,063 | 24.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 48 | 89 | $32,663 | $7,059 | 21.6% |
About Dr. Eddie Patton, M.D
Dr. Eddie Patton, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1720213770.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eddie Patton, M.D has received a total of $235,342 in payments from pharmaceutical and medical device companies, with $71,151 received in 2024. These payments were reported across 588 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($157,345).
As a Medicare-enrolled provider, Patton has provided services to 1,099 Medicare beneficiaries, totaling 10,848 services with total Medicare billing of $179,697. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Houston, TX
- Active Since 05/20/2009
- Last Updated 02/27/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720213770
Products in Payments
- ULTOMIRIS (Biological) $57,596
- SPINRAZA (Biological) $50,704
- VYVGART (Drug) $35,733
- HYQVIA (Biological) $17,068
- Spinraza (Biological) $9,831
- SOLIRIS (Drug) $6,839
- KISUNLA (Drug) $4,508
- UPLIZNA (Drug) $3,235
- Soliris (Drug) $2,617
- ADUHELM (Biological) $1,628
- NUPLAZID (Drug) $547.62
- TYSABRI (Biological) $498.49
- ACTIVA (Device) $416.34
- ACTHAR (Biological) $367.14
- Leqembi (Drug) $330.34
- INSPIRE (Device) $276.99
- UBRELVY (Drug) $260.97
- QULIPTA (Drug) $232.02
- KESIMPTA (Drug) $228.97
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $220.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Student in an Organized Health Care Education/Training Program $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Student in an Organized Health Care Education/Training Program $287,975
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Student in an Organized Health Care Education/Training Program $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Student in an Organized Health Care Education/Training Program $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401
Student in an Organized Health Care Education/Training Program $144,401
Sheetal Shroff, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $99,679
Student in an Organized Health Care Education/Training Program $99,679